Screening compound: DDWLWRFHEIPKQU-UHFFFAOYSA-N

Screening compound: DDWLWRFHEIPKQU-UHFFFAOYSA-N
Screening compound: DDWLWRFHEIPKQU-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
DDWLWRFHEIPKQU-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F724-0001

Molecular Formula

C27H29ClN4O3 (C27 H29 ClN4 O3)

Compound Name

6-(2-chlorobenzamido)-2-(4-cyclohexylpiperazin-1-yl)quinoline-4-carboxylic acid

IUPAC name

6-(2-chlorobenzamido)-2-(4-cyclohexylpiperazin-1-yl)quinoline-4-carboxylic acid

SMILES

OC(c1c(cc(cc2)NC(c(cccc3)c3Cl)=O)c2nc(N(CC2)CCN2C2CCCCC2)c1)=O

InChI

InChI=1S/C27H29ClN4O3/c28-23-9-5-4-8-20(23)26(33)29-18-10-11-24-21(16-18)22(27(34)35)17-25(30-24)32-14-12-31(13-15-32)19-6-2-1-3-7-19/h4-5,8-11,16-17,19H,1-3,6-7,12-15H2,(H,29,33)(H,34,35)

InChI Key

DDWLWRFHEIPKQU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27187754

DDWLWRFHEIPKQU-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Epigenetics Focused Set (26518 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Hemic and lymphatic
  • Cardiovascular
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • GPCR
  • Ion Channels
  • Kinases
  • Nuclear receptors
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with DDWLWRFHEIPKQU-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound DDWLWRFHEIPKQU-UHFFFAOYSA-N?
Check Price and Availability of DDWLWRFHEIPKQU-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of DDWLWRFHEIPKQU-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for DDWLWRFHEIPKQU-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for DDWLWRFHEIPKQU-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of DDWLWRFHEIPKQU-UHFFFAOYSA-N available by request